Erudio Healtherudio.com
Sponsor
PrECOG trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by PrECOG: PrE1005. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 2 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (PrECOG, LLC.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| PrE1005 NCT07285239 · PrECOG, LLC. | newly diagnosed multiple myeloma | Phase 3 | 28 | 3 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| PrECOG 0905 NCT03836209 · PrECOG, LLC. StandardView → | FLT3-mutated acute myeloid leukemia | Phase 2 | Standard | View | |||
| PrE0807 NCT03532451 · PrECOG, LLC. FocusedView → | cisplatin-ineligible muscle-invasive bladder cancer | Phase 1 | Focused | View | |||